134 related articles for article (PubMed ID: 37423478)
21. Dosimetric impact of a robust optimization approach to mitigate effects from rotational uncertainty in prostate intensity-modulated brachytherapy.
Morén B; Antaki M; Famulari G; Morcos M; Larsson T; Enger SA; Tedgren ÅC
Med Phys; 2023 Feb; 50(2):1029-1043. PubMed ID: 36478226
[TBL] [Abstract][Full Text] [Related]
22. Dynamic Modulated Brachytherapy (DMBT) Balloon Applicator for Accelerated Partial Breast Irradiation.
Guy CL; Oh S; Han DY; Kim S; Arthur D; Song WY
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):953-961. PubMed ID: 30910767
[TBL] [Abstract][Full Text] [Related]
23. Applying the column generation method to the intensity modulated high dose rate brachytherapy inverse planning problem.
Antaki M; Renaud MA; Morcos M; Seuntjens J; Enger SA
Phys Med Biol; 2023 Mar; 68(6):. PubMed ID: 36791469
[No Abstract] [Full Text] [Related]
24. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
Ishiyama H; Kitano M; Satoh T; Kotani S; Uemae M; Matsumoto K; Okusa H; Tabata K; Baba S; Hayakawa K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):23-8. PubMed ID: 19243900
[TBL] [Abstract][Full Text] [Related]
25. DVH-Based Inverse Planning Using Monte Carlo Dosimetry for LDR Prostate Brachytherapy.
Mountris KA; Visvikis D; Bert J
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):503-510. PubMed ID: 30315873
[TBL] [Abstract][Full Text] [Related]
26. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
Fukuda S; Seo Y; Shiomi H; Yamada Y; Ogata T; Morimoto M; Konishi K; Yoshioka Y; Ogawa K
J Radiat Res; 2014 Nov; 55(6):1114-21. PubMed ID: 24957754
[TBL] [Abstract][Full Text] [Related]
27. Three dimensional intensity modulated brachytherapy (IMBT): dosimetry algorithm and inverse treatment planning.
Shi C; Guo B; Cheng CY; Esquivel C; Eng T; Papanikolaou N
Med Phys; 2010 Jul; 37(7):3725-37. PubMed ID: 20831080
[TBL] [Abstract][Full Text] [Related]
28. A surrogate urethra for real-time planning of high-dose-rate prostate brachytherapy.
Halperin H; Hilts M; Crook J; Batchelar D; Tisseverasinghe S; Tetreault-LaFlamme A; Bachand F
Brachytherapy; 2019; 18(5):675-682. PubMed ID: 31248822
[TBL] [Abstract][Full Text] [Related]
29. Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Thwaites D; Henry A
Brachytherapy; 2014; 13(6):611-7. PubMed ID: 25085456
[TBL] [Abstract][Full Text] [Related]
30. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract][Full Text] [Related]
31. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous needle catheter selection and dwell time optimization for preplanning of high-dose-rate brachytherapy of prostate cancer.
Wang C; Gonzalez Y; Shen C; Hrycushko B; Jia X
Phys Med Biol; 2021 Mar; 66(5):055028. PubMed ID: 33264753
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.
Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Polgár C; Major T
Strahlenther Onkol; 2010 Jul; 186(7):388-95. PubMed ID: 20582396
[TBL] [Abstract][Full Text] [Related]
35. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
[TBL] [Abstract][Full Text] [Related]
36. Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer.
Mahdavi SS; Spadinger IT; Chng NT; Morris WJ
Brachytherapy; 2016; 15(5):642-9. PubMed ID: 27263060
[TBL] [Abstract][Full Text] [Related]
37. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study.
Giantsoudi D; Baltas D; Karabis A; Mavroidis P; Zamboglou N; Tselis N; Shi C; Papanikolaou N
Med Phys; 2013 Apr; 40(4):041704. PubMed ID: 23556874
[TBL] [Abstract][Full Text] [Related]
38. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
[TBL] [Abstract][Full Text] [Related]
39. Dosimetry Modeling for Focal Low-Dose-Rate Prostate Brachytherapy.
Al-Qaisieh B; Mason J; Bownes P; Henry A; Dickinson L; Ahmed HU; Emberton M; Langley S
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):787-93. PubMed ID: 25936808
[TBL] [Abstract][Full Text] [Related]
40. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
